Mural Oncology plc·4

Dec 18, 4:30 PM ET

Goodman Vicki L 4

4 · Mural Oncology plc · Filed Dec 18, 2023

Insider Transaction Report

Form 4
Period: 2023-12-14
Goodman Vicki L
Chief Medical Officer
Transactions
  • Award

    Ordinary Shares

    2023-12-14+73,01873,018 total
  • Award

    Stock Option (right to buy)

    2023-12-14+135,604135,604 total
    Exercise: $3.61Exp: 2033-12-13Ordinary Shares (135,604 underlying)
Footnotes (2)
  • [F1]Consists of ordinary shares issuable under 73,018 restricted stock units ("RSUs"). Each RSU represents the right to receive one ordinary share upon vesting. The RSUs are scheduled to vest with respect to 25% of the underlying ordinary shares on each of the first four anniversaries of November 6, 2023, subject to the reporting person's continued service with the Issuer.
  • [F2]This option was granted on December 14, 2023. The option is scheduled to vest with respect to 25% of the underlying ordinary shares on November 6, 2024 and the remaining 75% of the underlying ordinary shares shall vest in 12 equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4